Artelo Biosciences ARTL October 2021 Investor Presentation

Clinical-stage biopharmaceutical company developing a therapeutic pipeline focused on novel targets and significant unmet needs in cancer treatment. The company highlights its novel drug pipeline, proven leadership, robust patent estate, and near-term milestones across billion-dollar markets.